MEDICALSYSTEM BIOTECHNOLOGY CO., LTD Medicalsystem Biotechnology Co., Ltd Stock
Equities
300439
CNE100001Z25
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.87 CNY | +0.45% |
|
-3.80% | -23.60% |
| Apr. 18 | Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 22 | MedicalSystem Biotechnology Gets Nod to Market Fibrinogen Detection Kit | MT |
| Sales 2022 | 2.49B 344M | Sales 2023 | 1.89B 260M | Capitalization | 4.45B 614M |
|---|---|---|---|---|---|
| Net income 2022 | 199M 27.49M | Net income 2023 | 257M 35.5M | EV / Sales 2022 | 1.58 x |
| Net cash position 2022 | 555M 76.65M | Net cash position 2023 | 872M 120M | EV / Sales 2023 | 1.9 x |
| P/E ratio 2022 |
22.5
x | P/E ratio 2023 |
17.3
x | Employees | - |
| Yield 2022 |
0.9% | Yield 2023 |
-
| Free-Float | 51.29% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.45% | ||
| 1 week | -3.80% | ||
| Current month | -7.80% | ||
| 1 month | -9.58% | ||
| 3 months | -16.87% | ||
| 6 months | -23.27% | ||
| Current year | -23.60% |
1 week
8.34
9.28
1 month
8.3410.07
Current year
7.2811.86
1 year
7.2812.60
3 years
7.2829.90
5 years
7.2829.90
10 years
7.2878.84
| Managers | Title | Age | Since |
|---|---|---|---|
Ji Hua Zou
CEO | Chief Executive Officer | 45 | 07-03-31 |
Bing De Zou
FOU | Founder | 52 | 03-07-21 |
Xiao Yan Tian
CHM | Chairman | 44 | 15-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bing De Zou
FOU | Founder | 52 | 03-07-21 |
Ji Hua Zou
CEO | Chief Executive Officer | 45 | 07-03-31 |
Cheng Ai Li
BRD | Director/Board Member | 45 | 17-12-21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 8.87 | +0.45% | 5,469,800 |
| 24-04-18 | 8.83 | -0.23% | 2,933,300 |
| 24-04-17 | 8.85 | +6.12% | 4,864,700 |
| 24-04-16 | 8.34 | -5.12% | 5,325,600 |
| 24-04-15 | 8.79 | -4.66% | 6,555,500 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotes
MedicalSystem Biotechnology Co., Ltd. is a China-based company engaged in the research and development, manufacture and distribution of in-vitro diagnostic products. The Companyâs in-vitro diagnostic products include in-vitro diagnostic reagent and in-vitro diagnostic instrument. In addition, the Company is also involved in the provision of third-party medical diagnosis services, as well as the production and distribution of reagent raw materials. The Company mainly operates businesses in domestic market.
Calendar
2024-04-23
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -23.60% | 468M | |
| -1.04% | 12.47B | |
| -17.29% | 6.99B | |
| -2.21% | 5.1B | |
| +2.92% | 4.27B | |
| -4.79% | 4.27B | |
| -50.07% | 3.45B | |
| +7.65% | 2.61B | |
| -15.92% | 2.08B | |
| -3.34% | 1.67B |
- Stock Market
- Equities
- 300439 Stock
